Skip to main content
Figure 6 | Breast Cancer Research

Figure 6

From: The mTOR effectors 4EBP1 and S6K2 are frequently coexpressed, and associated with a poor prognosis and endocrine resistance in breast cancer: a retrospective study including patients from the randomised Stockholm tamoxifen trials

Figure 6

Distant recurrence-free survival for ER-positive/PgR-positive breast cancer patients in Stockholm 3 treated or not with tamoxifen in relation to 4EBP1 cytoplasmic protein. Distant recurrence-free survival (DRFS) for breast cancer patients in the Stockholm 3 cohort treated with tamoxifen (Tam) versus no tamoxifen (no Tam) in the ER-positive/PgR-positive subgroup in relation to (a) low and (b) high cytoplasmic 4E-binding protein 1 (4EBP1) protein levels. ER, oestrogen receptor alpha; PgR, progesterone receptor.

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us